tissues and spread to distant area of the body. 2 The female breast is made up of milk producing glands (lobules), tiny tubes that carry the milk from the lobules to the nipple (ducts) and fatty tissue, connective tissue, lymphatic vessels and blood vessels. Breast cancer is the most common cancer in developed countries and second leading cause of cancer death in women (after lung cancer). 3 Lymphatic system includes small beans shaped immune system cells called lymph nodes. It is connected with lymphatic vessels under the arms (axillaries nodes).Some lymph nodes connected to lymphatic vessels inside the chest called internal mammary nodes. Cancer is predominantly a malignancy, which have been increasing in incidence in some population over the past few decades due to improvement in screening. 4 Cancer screening is an important landmark to detect cancer before appearing symptoms. It includes various tests such as biopsy, pap smear test, urine test and blood test. It is useful in cancer prevention, early detection and early treatment. Early diagnosis may useful in higher rate of successful treatment. People with family history which are at higher risk of developing cancer can be screen with Selective cancer screening.
It is important for reducing cancer at affordable cost to reduce economic burden of India. Women go for cancer screening at later stage once they reach in advance stage of cancer. Screening must be safe and effective. 5 With the rising number of public health issues facing the public today, comprehensive and clear health communication approach is becoming even more important to ensure the efficient and safe delivery of health services. Proper implementation of health care policy is a unique skill to bridge the gap between the consumers and the health system. It could be achieved by optimizing and creating relationships and community partnerships.
METHODS
It is an observational epidemiological study. The research was done by using data of women breast and cervical cancer collected through different hospitals of Ajmer, which help in the progress of research scale. The next stage comprises of qualitative data collected through questionnaire. Cancer research approach describes the qualitative data collection approaches and scale development procedure. It proportionally develops to quantitative aspects of cancer research with the section on data collection method, with the sampling approach. The non-response bias issues and data cleaning process would explain in this section. After this the statistical methods and tools probably discussed for analysis. Case control study has several biases. 5 Factors which are not considered may drive the observed association Participants of current study were registered and diagnosed with cervical and breast cancer in different hospital of Ajmer municipal area between January 2011-March 2015.These women have a record in cervical and breast screening call and recall system. All control women were matched with experimental women on age and residential area. They were selected at random order. We associated the effect of screening separately by cancer stage. Finally, we considered both all available data and only data obtained subsequently to examine possible trends associated with changes in screening practice.
To understand the reason for screening being more effective in older women we also looked, by the proportion of cases classified as screen detected, never screened or lapse.
Statistical analysis
To estimate the association between screening and incidence of cervical and breast cancer conditional logistic regression is used. Association between them is expressed as odds ratio for developing cervical and breast cancer. All age range is in inclusive series. Odds ratios are used to compare the relative odds of the occurrence of the outcome of disease. 7 The odds ratio can also be used to determine whether a particular exposure is a risk factor for a particular outcome and to compare the magnitude of various risk factors for that outcome. The 95% confidence interval is used to estimate the precision of the odds ratio. Our study confirms that cervical and breast cancer screening in women aged 30-35 is less effective than in older women. By studying the effect of screening in smaller age groups, it indicate that the efficacy of screening decreases with decreasing age, even within the age range 30-35 (Table 1 ). There is evidence that screening was associated with a 32% reduction of cervical cancer ( Figure 2 ) and 48% reduction of breast cancer in women aged 45 ( Figure 3 ). There is 41% reduction of cervical cancer and 52% reduction of breast cancer in women aged 55. There is no evidence of reduction in incidence of cervical and breast cancer at 35 (Odd Ratio 1.12, 95% confidence interval 0.84 to 1.52).
RESULTS
Screening in later age reduces incidence and mortality from cervical and breast cancer. The study is design to eliminate most of the biases that affect case-control studies, our observed associations are either causal or the result of confounding. The association in different age bands within the same study argues strongly that these effects are real. It may be biological reasons for cervical and breast screening working better in older women. Specificity of screening is less in women aged 30-35 because human papilloma -virus (HPV) infections are so much more common in younger women. However it does not; explain why the sensitivity of screening should be less.
DISCUSSION
Review of the screening histories of women aged 30-35 with a diagnosis of cervical and breast cancer suggests that some of the cancers occurred through a lack of screening. This means that the opportunities for detecting the small proportion of cervical and breast cancer grade III in women in their early 30s that will progress to cancer within at most a few years are small. In most cases of cervical and breast grade III detected will be slow growing and could safely be left for several years; but the rare cases that are progressing rapidly will probably be missed in sampling. 9 Development of screening strategies based on the estimation of the burden of cancer should be attributable to risk factor at regional level. 10 The strength of screening should be explain and examine in a systematic way. The association, which is not reflective of an original causal chain, will not provide a strong basis of dropping cancer burden. Assessment of screening role in reducing cancer burden should describe upon the best available facts.
CONCLUSION
To significantly reduce the breast and cervical cancer mortality, screening should be sturdily intensified to improve long term effectiveness. Quality assessment of early screening should be done via early indicators. New screening modalities have been introduced and some of them should be gradually incorporated into society practice. 
